These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 10611412)

  • 1. Effects of ACEA-1328, a NMDA receptor/glycine site antagonist, on U50,488H-induced antinociception and tolerance.
    Lutfy K; Doan P; Nguyen M; Weber E
    Eur J Pharmacol; 1999 Nov; 384(1):1-5. PubMed ID: 10611412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACEA-1328, an NMDA receptor antagonist, increases the potency of morphine and U50,488H in the tail flick test in mice.
    Lutfy K; Doan P; Nugyen M; Weber E
    Pharmacol Res; 1998 Dec; 38(6):453-60. PubMed ID: 9990654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine.
    Lutfy K; Doan P; Weber E
    Pharmacol Res; 1999 Nov; 40(5):435-42. PubMed ID: 10527659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulatory role of ginsenosides injected intrathecally or intracerebroventricularly in the production of antinociception induced by kappa-opioid receptor agonist administered intracerebroventricularly in the mouse.
    Suh HW; Song DK; Huh SO; Kim YH
    Planta Med; 2000 Jun; 66(5):412-7. PubMed ID: 10909259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term voluntary access to running wheels decreases kappa-opioid antinociception.
    D'Anci KE; Gerstein AV; Kanarek RB
    Pharmacol Biochem Behav; 2000 Jun; 66(2):343-6. PubMed ID: 10880688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of ATPM [(-)-3-aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed kappa-agonist and mu-agonist/-antagonist that attenuates morphine antinociceptive tolerance and heroin self-administration behavior.
    Wang YJ; Tao YM; Li FY; Wang YH; Xu XJ; Chen J; Cao YL; Chi ZQ; Neumeyer JL; Zhang A; Liu JG
    J Pharmacol Exp Ther; 2009 Apr; 329(1):306-13. PubMed ID: 19136637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance develops to the antinociceptive and motor impairing effects of ACEA-1416, a NMDA receptor antagonist, in the formalin and rotarod test in mice.
    Lutfy K; Weber E
    Pharmacol Res; 1998 Apr; 37(4):295-302. PubMed ID: 9634646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intrathecally injected histamine receptor antagonists on the antinociception induced by morphine, beta-endorphin, and U50, 488H administered intrathecally in the mouse.
    Suh HW; Song DK; Choi YS; Kim YH
    Neuropeptides; 1996 Oct; 30(5):485-90. PubMed ID: 8923512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
    Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T
    J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain.
    Baker AK; Hoffmann VL; Meert TF
    Pharmacol Biochem Behav; 2002 Dec; 74(1):73-86. PubMed ID: 12376154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of morphine tolerance by ACEA-1328, a novel NMDA receptor/glycine site antagonist.
    Lutfy K; Shen KZ; Kwon IS; Cai SX; Woodward RM; Keana JF; Weber E
    Eur J Pharmacol; 1995 Jan; 273(1-2):187-9. PubMed ID: 7737313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of endothelin-A receptor antagonist on mu, delta and kappa opioid receptor-mediated antinociception in mice.
    Bhalla S; Zhang Z; Patterson N; Gulati A
    Eur J Pharmacol; 2010 Jun; 635(1-3):62-71. PubMed ID: 20303944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-type Ca2+ channel modulation by dihydropyridines potentiates kappa-opioid receptor agonist induced acute analgesia and inhibits development of tolerance in rats.
    Gullapalli S; Ramarao P
    Neuropharmacology; 2002 Mar; 42(4):467-75. PubMed ID: 11955518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of histamine receptor antagonists injected intrathecally on antinociception induced by opioids administered intracerebroventricularly in the mouse.
    Suh HW; Chung KM; Kim YH; Huh SO; Song DK
    Neuropeptides; 1999 Apr; 33(2):121-9. PubMed ID: 10657481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of protein kinase C-epsilon in the development of kappa-opioid receptor tolerance to U50,488H in rat ventricular myocytes.
    Zhou JJ; Bian JS; Pei JM; Wu S; Li HY; Wong TM
    Br J Pharmacol; 2002 Apr; 135(7):1675-84. PubMed ID: 11934807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-NMDA receptor antagonist attenuates antinociception induced by morphine but not beta-endorphin, D-Pen2-D-Pen5-enkephalin, and U50, 488H administered intracerebroventricularly in mice.
    Suh HW; Choi YS; Yoo JS; Song DK; Kim YH; Tseng LF
    Neuropeptides; 1995 Feb; 28(2):125-9. PubMed ID: 7746356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex difference in κ-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig.
    Wang YJ; Rasakham K; Huang P; Chudnovskaya D; Cowan A; Liu-Chen LY
    J Pharmacol Exp Ther; 2011 Nov; 339(2):438-50. PubMed ID: 21841040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of benzodiazepine-GABAA receptor complex in attenuation of U-50,488H-induced analgesia and inhibition of tolerance to its analgesia by ginseng total saponin in mice.
    Nemmani KV; Ramarao P
    Life Sci; 2002 Mar; 70(15):1727-40. PubMed ID: 12002518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.
    Lohmann AB; Welch SP
    Eur J Pharmacol; 1999 Dec; 385(2-3):119-27. PubMed ID: 10607867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential potentiative effects of glutamate receptor antagonists in the production of antinociception induced by opioids administered intrathecally in the mouse.
    Suh H; Song D; Huh S; Kim YH
    Brain Res Bull; 2000 May; 52(2):143-50. PubMed ID: 10808085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.